Championing Change: Celebrating Cardiometabolic Health Congress (CMHC) Women Faculty
It’s Women’s History Month, and now, more than ever before, we are at a tipping point. There is increased cognizance of gender inequality and the importance of inclusive and diverse approaches to medical research. The Gender Gap: Women in Science by the Numbers: Half of all graduate and postgraduate students are women. Yet, women make […]
Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care
The not-so-sudden rise of weight loss ”wonder” drugs for T2D and obesity This World Obesity Day, March 4, 2024, weight loss drugs dominate discussions and raise new questions for clinicians. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have been used to treat type 2 diabetes (T2D) since the approval of Byetta (exenatide) in 2005. In the […]
3 Powerful Strategies: Combatting Cardiometabolic Risk Factors for Black AmericansÂ
This February the intersection of American Heart Health Month and Black History Month underscores the deeply profound and layered legacy of health inequality in America—which, sadly, persists to this day. Black History Month is a poignant backdrop to the alarming rise in obesity and type 2 diabetes, particularly among those of marginalized populations. This troubling […]
The 10 Most Common Diagnoses and Procedures in Primary Care
Spearheading the fight against cardiometabolic disease alongside cardiologists and cardiometabolic specialists are primary care physicians – integral members of the healthcare system. Leaders in population health management and preventative personalized patient care, PCPs play a vital role in improving outcomes and reducing mortality rates, ultimately contributing to the increased longevity and life expectancy seen in […]
